Diabetes drug linked to increased bladder cancer risk
A new study of 145,806 people who took pioglitazone compared to other oral diabetes drugs showed that it raises the risk of bladder cancer by 63%. Results were published in the BMJ.
NHS Direct
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
More News: Actos | Bladder Cancer | Cancer | Cancer & Oncology | Diabetes | Endocrinology | Oral Cancer | Study